Archive for the ‘authorship issues’ Category
The properties of pine needles in northwestern China differ — both inside and out — depending on where on the slope of a mountain they are situated. The properties of a recent paper on this phenomenon have recently changed from “published” to “retracted.”
It appears that some of the authors didn’t realize it had been submitted to The Scientific World Journal. The paper has not been cited, according to Thomson Scientific’s Web of Knowledge.
Eurosurveillance is investigating potential problems with study on the deadly breakout of Middle East respiratory syndrome coronavirus (MERS-CoV) in South Korea. The notice was issued after the journal discovered that study data might have been used without permission.
“Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015,” was published last month by a group of researchers at the Gyeonggi Infectious Disease Control Center in Korea, and details 37 cases of people at one hospital, one portion of the nearly 200 who’ve developed the new respiratory infection since the outbreak began. The researchers tracked the path of infection from one initial patient to 25 secondary cases, who then infected 11 additional people. As the researchers note:
Yup, this happened: “Mystery” writer impersonated cardiovascular pathologist, penned published letter
A 2014 letter in the Journal of the American College of Cardiology has been retracted because editors aren’t sure who wrote it.
“Can Grayscale IVUS Detect Necrotic Core-Rich Plaque?”, a letter on the potential of intravascular ultrasound, was submitted under the name of a researcher at the University of Copenhagen, Erling Falk. The paper was sent with a Gmail account (a technique used by some academics to conduct fake peer reviews), and editors communicated with the author through the acceptance process.
Shortly after the letter was published, Erling Falk of Aarhus University contacted the journal and asked who wrote the letter. They discovered that nobody by that name worked at the University of Copenhagen and emails to the author’s Gmail address went unanswered. So the journal issued a retraction.
Here’s the complete notice:
An economist in Taiwan has retracted a paper about from Economic Development Quarterly because it was “published in error.”
The paper — first published online March 5, 2013 — addresses the influence of information and communication technology on economic growth.
According to the notice, the paper included “the original dataset and excerpts from an earlier draft of the paper co-written by the author and colleagues.” The only listed author, Yi-Chia Wang, asked that the article be retracted before making it into print, but it looks like it was included in the February, 2015 issue of the journal.
The paper, “N, S co-doped graphene quantum dots from a single source precursor used for photodynamic cancer therapy under two-photon excitation,” was ostensibly written by nine researchers at the Collaborative Innovation Center for Marine Biomass Fiber, Materials and Textiles of Shandong Province, the Shandong Sino-Japanese Center for Collaborative Research of Carbon Nanomaterials, Laboratory of Fiber Materials and Modern Textiles, the Growing Base for State Key Laboratory at the College of Chemical Science and Engineering at Qingdao University, and Mayo Clinic, in Rochester, Minn.
Authors from Xinxiang Medical University in Weihui, China, are retracting a 2014 paper in Molecular Biology Reports because… well, because lots of things.
The researchers exposed nine rats to acute levels of alcohol then compared them to unexposed
mice rats, noting differences in gene expression and molecular pathways.
But no one is toasting these findings anymore. Here are the details behind the retraction, courtesy of the notice:
The first author of a review article on extracting pharmacological compounds from marine organisms, published in the Asian Pacific Journal of Tropical Biomedicine, has retracted it due to plagiarism.
There were also some authorship issues, according to the retraction notice for the paper, which absolves the last author, based at Pondicherry University in India, from responsibility:
This article has been retracted at the request of the Editor-in-Chief and the First Author. Both the first author and the journal’s editor confirmed that Dr. A Yogamoorthi is not responsible for the plagiarism since his/her name was added without consent.
There is one other author, R. Siva Sankar, also based at Pondicherry. Somewhere along the way, according to the retraction note, the paper scooped up wording from six papers previously published by researchers in Australia. Here’s more from the retraction note for “Antimicrobial secondary metabolites from marine gastropod egg capsules and egg masses”: Read the rest of this entry »
Yihang Shen published a paper using his PhD research on the molecular biology of fetal rodent livers earlier this year in DNA and Cell Biology. Unfortunately, he didn’t have permission to publish the data. He also omitted the names of people who participated in the research, and listed an incorrect funding source.
The “cited grant,” according to the journal editor, was a grant awarded to Richard Finnell, a UT Austin researcher who often works with Shen’s PhD advisor at Shanghai Jiao Tong University, the well-known geneticist Fanyi Zeng.
The corresponding author of a 2014 paper in the Indian Journal of Medical and Paediatric Oncology has retracted the article because he was a bit too generous with his list of coauthors.
The article, “Outcome of neoadjuvant chemotherapy in locally advanced breast cancer: A tertiary care centre experience,” reviewed medical records from a local population of breast cancer patients treated with chemotherapy. It came from a group at the Post Graduate Institute of Medical Education and Research, in Chandigarh. The first author was Tapesh Bhattacharyya, followed by four other names.
A 2002 paper has been retracted by Cancer after some of the authors notified the journal that they hadn’t agreed to submit it — and an investigation found that a number of the patients described had been made up.
Here’s the notice for “Radioimmunotherapy of small-volume disease of metastatic colorectal cancer: results of a phase II trial with the iodine-131–labeled humanized anti–carcinoembryonic antigen antibody hMN-14:” Read the rest of this entry »